Pharmaceuticals News

Applied Biologics treats first patient in Phase 3 BIOxHEAL™ clinical trial for diabetic foot ulcers.

Alembic Therapeutics LLC is dedicated to delivering high-quality pharmaceutical products and innovative healthcare solutions that improve patient outcomes

Mr. Vat-Ho's appointment adds more than 20 years of oncology, biopharma and capital markets experience, including senior roles in transactions totaling more than $25 billion in aggregate value Mr....

23andMe Research Institute names its first Scientific Advisory Board, uniting leaders in genomics, AI, gene editing, and medicine to support its mission.

— Establishes QSYMIA as one of the most affordable branded weight-management options available in the United States — Effective immediately, uniform pricing across all four doses lowers QSYMIA’s...

WARRENDALE, Pa., Oct. 13, 2026 (GLOBE NEWSWIRE) -- ECM Therapeutics, Inc. today announced early clinical results suggesting its extracellular matrix (ECM) hydrogel, ECMT-100, could meaningfully...

NEW YORK and WALTHAM, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to...

October 13, 2026 Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP Update on expected timing of pre-specified futility analysis and...

Randomized, placebo-controlled study to evaluate the safety, tolerability, and efficacy in a robust, two-part study First-in-class therapeutic targets Alveolar Epithelial Type 2 (AEC2) cells with the...

CAMBRIDGE, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...